Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-06

FDA Approved: XADAGO — Supplemental Application (MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for XADAGO (safinamide mesylate) submitted by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc., exp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xadago (safinamide)

Snippet

SUPPL AP for XADAGO (SAFINAMIDE MESYLATE)